Glucose in dialisate for hemodialysis
At the present time there are no theoretical or practical reasons for adding glucose to the dialysis fluid used in hemodialysis. There is one exception hemodialysis for small infants. On the contrary, there are many reasons for abandoning the use of glucose in the preparation of dialysate. Among these are a) the ease of achieving ultrafiltration without using osmotic agents. b) the need to avoid pyrogenic reactions from bacterial growth, which in turn is favoured by glucose, c) the need to prevent hypoglycemic reactions due to glucose mediated insulin hypersecretion, d) the short schedules of hemodialysis treatment, which do not require energy administration in order to prevent neoglucogenesis, e) the eventual (hitherto undemonstrated) worsening of hyperlipidemia. tients and the increased incidence of death from cardiovascular diseases in hemodialysis patients have promoted much concern about the use of carbohydrate in the dialysate. However the reduction of tryglyceride observed after switching patients to a glucose free dialysate, which is evident in some experiments (2), is negated by the data of Hubner (3) and of Dombeck (4) . This is only to refer to some aspects of this controversy, without denying the need to control all the factors which may aggravate the eventual link between lipid metabolism and cardiovascular accidents in uremia.
There is enough evidence that in the hemodialysis of children the addition of glucose to the dialysate may be beneficial (5) (6) (7) . This evidence has been reaffirmed recently by Langfield et al (8) for children weighing less than 10 kilograms. On the basis of experience obtained in 50 patients, they recommended increasing the glucose content to 250-670 mg/dl to prevent changes in osmolality caused by the removal of urea by the dialyzer and to control post dialysis urea rebound.
Glucose in the dialysate for peritoneal dialysis
The removal of fluid during peritoneal dialysis may be described in terms of transcapillary ultrafiltration (9) , as function of the hydrostatic pressure gradient (capillaryinterstitial fluid) and of the osmotic pressure gradient (plasma -interstitial fluid).
The osmotic gradient is the real limiting factor in removing adequate amounts of fluids. For this reason glucose is added to the dialysate in concentrations of 1.50-7.00 g/dl. The highest concentration is not suitable for routine treatment, and in clinical practice ultrafiltration is achieved by using glucose concentrations of 1.50-
g/dl.
There are several technical aspects in preparing dialysate with high glucose concentrations: the most crucial concerns heat sterilization, which results in caramelizing and in the generation of toxic products suchs as 5-hydroxymethyl-furfurol (furfurol occurs in artificial oil of ants). For this reason, sterilization is achieved at a pH 5.5 by using substances such as hydrochloric acid and sodium bisulfite, which may alter the membrane.
It has been stressed (10) that a dialysate glucose concentration of 4.25 g/dl in a patient with a plasma glucose of 0.1 g/dl results in a maximum potential gradient of 231 mOsm (4,381 mm Hg). Such a maximum gradient is never operative, for several reasons: the small Staverman's reflection coefficient for glucose, 2) the entry of glucose into the patient, 3) the movement of water toward the peritoneal cavity. So the gradient operates maximally only briefly. As demonstrated by Rubin et al (11) , a maximum effect is obtained within the first 20 minutes. For this reason it has been suggested (10) that the nurse treating patients with dextrose concentrations of 4.25 g/dl should check the vital signs in the first 20 minutes, at which time hypertension may supervene.
The entry of glucose into the patient has not received enough attention. It has usually been discussed in terms of reduced efficiency for water removal (12) . Our group was interested in quantifying the concept of glucose entry into the patient in terms of energy input and was able to calculate a daily input of 200 g/day when working with 5 echanges per day -2 with dextrose concentrations of 4.25 g/dl - (13) . Furthermohe, we were also able to show that this glucose load did not cause eventual impaired glucose utilization (K) during intravenous glucose tolerance tests on both adults and children 14, 15) . This input of glucose in now intriguing those CAPD supporters who cannot overlook the fact that in normal people an association between increased carbohydrate intake and elevated triglyceride levels was demonstrated some 20 years ago (16) . So the risk of hyperlipidemia and obesity connected with CAPD therapy have been duly stressed (17) (18) (19) (20) (21) (22) but on the basis of very little data. The controverses about the atherogenic risk of CAPD is still going on, and at the Berlin Meeting the risk was emphasized and neglected at the same time (23). Turgan et al. (24) , however, were able to show that serum triglyceride levels did not increase during CAPD, neither did basal insulin levels increase, while the intravenous glucose tolerance test was nearly normal.
In our group we have considered the energy input of great relevance to nutrition and have used the peritoneal cavity as a simplified gut in adults and children (25, 26) 226 with chronic and acute renal failure, including patients with acute renal failure due to the recent earth-quake (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) .
Alternatives to glucose for peritoneal dialysis Dextran (29) , xylitol (30) , fructose (31, 32) , sorbitol (33) have been given up for various reasons (35) (Vidt 1973) , while experimentation on amino acids and polyanions is still going on. Oreopoulos et al. (19) have provided evidence that amino acid could be used as osmotic agents in both animals and humans. Their results are encouraging and deserve further research. At this time, however, these should be some concern about 1) the effects of glucogenetic amino acids, 2) the effects of ketogenetic amino acids, 3) the possibility of eventual amino acid imbalance (36), 4) the need for determining what is the ideal amino acid solution.
Nolph et al. (37) (38) have provided an excellent piece of work with Poly (sodium acrilate) and with Dextrase sulfate sodium, Neoplasma gel (succynilated gelatin), and disodium polyethilene maleate. Their results are promising and may disclose a new approach to be used in man.
